Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030567 (
Parkinson's disease
)
63,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Aminoacyl-tRNA synthetase-interacting multifunctional protein type 2 was recently identified as an authentic substrate of the ubiquitin E3 ligase, parkin, a gene associated with autosomal recessive juvenile parkinsonism. Far upstream element-binding protein 1 is known to be degraded in an aminoacyl-tRNA synthetase interacting multifunctional protein type 2 dependent manner, which is crucial for lung cell maturation in early development. Therefore, we wondered whether
far upstream element-binding protein
1 levels are altered in the absence of Parkin and in
Parkinson disease
. We herein report that
far upstream element-binding protein
1 accumulates in Parkin knock-out mice, patients with autosomal recessive juvenile parkinsonism, sporadic
Parkinson disease
, and diffuse Lewy Body disease as well as the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of
Parkinson disease
. Moreover, Parkin interacts with and ubiquitinates
far upstream element-binding protein
1 facilitating its degradation through the ubiquitin proteasome system. Taken together, these results suggest that
far upstream element-binding protein
1 is an authentic substrate of Parkin and that
far upstream element-binding protein
1 might play an important role in development of
Parkinson disease
pathology along with aminoacyl-tRNA synthetase interacting multifunctional protein type 2.
...
PMID:Identification of far upstream element-binding protein-1 as an authentic Parkin substrate. 1667 20